Navigation Links
SyntheMed, Inc. Announces Stockholder Approval of Planned Merger With Pathfinder, LLC
Date:8/25/2011

RINGWOOD, N.J., Aug. 25, 2011 /PRNewswire/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD; Pink Sheets: SYMD) announced that its stockholders approved the planned merger with Pathfinder, LLC at SyntheMed's special meeting of stockholders held today.  In excess of 99% of the votes cast were voted in favor of the merger.  The proposed merger with Pathfinder was previously announced and is described in detail in SyntheMed's definitive proxy statement filed with the Securities and Exchange Commission on July 26, 2011.  The merger has been approved by Pathfinder's members and is expected to close in the next ten days, subject to satisfaction or waiver of customary and other closing conditions.  

Dr. Richard Franklin, M.D., Ph.D., SyntheMed's Executive Chairman, and CEO and President of Pathfinder, commented, "I am pleased at the support shown by SyntheMed's stockholders.  Pathfinder has great potential, and I look forward to closing the merger and beginning a new direction for the Company."

About Pathfinder

Pathfinder is developing a novel cell-based therapy with the potential to revolutionize the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. Leveraging its internal discovery of Pathfinder Cells ("PCs") and a proprietary means of isolating these cells from surrounding tissue, Pathfinder is pioneering a new field in regenerative medicine. PCs are a newly identified mammalian cell type present in very low quantities in a variety of different organs, including the kidney, liver, pancreas, lymph nodes, myometrium, bone marrow and blood.

Early studies indicate that PCs stimulate regeneration of damaged tissues without the cells themselves being incorporated into the new
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pathfinder LLC and SyntheMed, Inc. Announce Merger Agreement
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Anesiva Announces Second Quarter 2008 Financial Results and Update
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. ThirdBiotech Announces Kemeta as Newest Sponsor
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... LOS ANGELES , May 20, 2013 ... San Francisco , James ... of Clinical Psychiatry at the Semel Institute for Neuroscience ... of Medicine at the University of California ... in both Child and Adolescent Psychopharmacology and ADHD at ...
(Date:5/20/2013)... BALTIMORE , May 20, 2013 /PRNewswire/ ... private-public partnership focusing on commercializing market-relevant biohealth innovations ... Central Maryland , today announced its ... first Entrepreneur-in-Residence (EIR) for BHI at the National ... and Blood Institute (NHLBI). Dr. Aiyar will ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Researchers from the ... the connection between lower back pain, and the acne causing ... in the system the bacteria seek out oxygen deprived location ... in the spinal column, P.acnes has the ability to live ... , Fernando Perez, a spokesman for “ The best acne ...
(Date:5/20/2013)... 2013 The World Molecular Imaging Society ... Lisa Baird as Executive Director. Baird will assume ... The WMIS vision is to encompass and promote ... effectively treat diseases in the developed and developing world. ... in 2011 by integrating the Academy of Molecular Imaging ...
Breaking Biology Technology:Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2WMIS Appoints Lisa Baird as Next Executive Director 2
... and opportunities for micro and nano technologies. These challenges ... in the control and understanding of their behaviour. , ... of fibre analysis at the micro and nano-scale using ... SPM techniques. , Topics include fundamental effects of topography ...
... Calif., May 14 VaxGen,Inc. (OTC Bulletin Board: VXGN), ... cash expenditures following the,most recent restructuring undertaken on April ... going forward are unlikely to exceed,$1 million, made up ... to the Company,s real estate and facility, estimated at ...
... 14 Ardea Biosciences, Inc.,(Nasdaq: RDEA ) today announced that ... (MEK) inhibitor, RDEA119,at Digestive Disease Week (DDW) 2008 in San Diego., ... Date/Time: Tuesday, May 20, 2008 at 3:30 p.m. ... Potent and Highly Selective MEK Inhibitor ...
Cached Biology Technology:Micro and Nano Scale Characterization of Fibers 2Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 2Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 3Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008 2
(Date:5/18/2013)... An increasing number of U.S. children are ... according to research presented at Digestive Disease Week ... researchers at the Cleveland Clinic Children,s Hospital found ... exhaled breath compared to their lean counterparts. The ... that can be correlated to potential complications associated ...
(Date:5/17/2013)... Scientists investigating the interaction of a group of proteins ... damage have identified a new target that could increase ... the University,s School of Biochemistry and published in the ... Reviews, could eventually lead to new therapies for stroke ... earlier work by the team which identified a protein, ...
(Date:5/17/2013)... team of scientists using a new X-ray method recorded ... frog embryo in greater detail than ever before., This ... and the search for new treatments for genetic diseases., ... Technologie in Germany, in collaboration with the Advanced Photon ... Laboratory, released the most precise depiction ever of the ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3SUMO wrestling cells reveal new protective mechanism target for stroke 2New X-ray method shows how frog embryos could help thwart disease 2
... diseases are still one of the biggest challenges to medical ... humans, their ability to harness the biology of their human ... target with medical treatment. Scientists at the University of ... University of Colorado, have shown for the first time how ...
... Northeast Public Radio and the Cary Institute of Ecosystem Studies ... look at our changing environment. The collaboration was formed to ... raising awareness about the science that underpins environmental issues. ... 11:10 AM and 4:04 PM on WAMC. With the ...
... Consider your audience. According to a new report published online ... Press publication, that rule of thumb is not lost on ... call about the presence of a snake when others in ... the new evidence shows. The findings suggest that ...
Cached Biology News:Hepatitis C virus hijacks liver microRNA 2Cary Institute and WAMC debut new environment radio show 2Before sounding an alarm, chimps consider their audience 2
Automated Cell Culture Flask...
Cell Culture Flask, 75 cm, treated polystyrene...
... style shaker flasks have three extra deep ... solutions to improve oxygen or gas transfer ... The long neck reduces splashing and is ... wall thickness provides the proper balance between ...
... 100 IS System is a compact analysis system ... lasers, optics, fluidics, a controller, advanced digital signal ... compact lab analysis system includes the Luminex 100, ... has a DMF file at the FDA, and ...
Biology Products: